Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin [NA]

View source ↗

Summary

A terminated clinical trial evaluated whether papillary epinephrine spraying lowers post-ERCP pancreatitis in patients receiving rectal indomethacin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epinephrine (papillary spray) (epinephrine)
  • INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Pancreatitis, Endoscopic Retrograde Cholangiopancreatography | NA | Status: TERMINATED